{"nct_id":"NCT01949090","title":"Immunogenicity and Safety Study of Different Formulations of GlaxoSmithKline (GSK) Biologicals H7N1 Influenza Vaccine Administered to Adults 65 Years of Age and Older","status":"COMPLETED","status_verified_date":"2017-11","start_date":"2013-09-25","start_date_type":"ACTUAL","primary_completion_date":"2013-12-04","primary_completion_date_type":"ACTUAL","completion_date":"2014-10-23","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["GSK"]}